Recombinant Human GLS Protein，His

The study of GLS (glutaminase) recombinant proteins has gained significant attention due to their crucial role in cellular metabolism and cancer biology. Glutaminase catalyzes the conversion of glutamine to glutamate, a key process in glutamine metabolism that supports cancer cell growth and proliferation. Abnormal activation of GLS has been implicated in various cancers, making it an attractive target for therapeutic intervention. Researchers have been exploring GLS recombinant proteins to better understand their structural properties, enzymatic mechanisms, and regulatory functions. The recombinant production of GLS allows for the examination of its activity in controlled laboratory settings, facilitating the identification of potential inhibitors that could disrupt its function in tumor cells. Furthermore, advancements in protein engineering and expression systems have enabled improved yields and functionalities of these recombinant proteins. This research is particularly valuable in the context of developing novel cancer treatments that target metabolic pathways, potentially leading to more effective therapies for patients with glutamine-dependent tumors. As the understanding of GLS's role in metabolic reprogramming deepens, studies focusing on GLS recombinant proteins are paving the way for innovative approaches to combat cancer and other diseases associated with dysregulated glutamine metabolism.